White label – Pompe disease - ClinicalTrials.eu

Study of SAR443579 Infusion for Adults and Children with Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia, HR-MDS, or BPDCN

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study of RO7269162 in people at risk for or with early-stage Alzheimer’s Disease: Effects on brain amyloid buildup

Not recruiting

2 1 1
Investigated Drugs:
Study on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease

Not recruiting

2 1
Investigated Diseases:
- Acute graft versus host disease
Investigated Drugs:
- Allogeneic Mesenchymoangioblast-Derived Mesenchymal Stem Cells
Study on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction

Not recruiting

3 1 1
Investigated Diseases:
- Cardiac failure
- Left ventricular dysfunction
Investigated Drugs:
- Vericiguat
+7
Long-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension

Not recruiting

3 1 1
Investigated Diseases:
- Pulmonary arterial hypertension
Investigated Drugs:
- Imatinib
+8
Study on Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

2 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
- Belantamab Mafodotin
+1
Study on Berzosertib and Gemcitabine for Adults with Advanced or Metastatic Soft-Tissue Leiomyosarcomas

Not recruiting

2 1 1 1
Investigated Diseases:
- Soft tissue sarcoma
Investigated Drugs:
- Berzosertib
- Gemcitabine Hydrochloride
Study on the Safety of Tafasitamab and Lenalidomide for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Not recruiting

1 1 1 1
Investigated Diseases:
- Diffuse large B-cell lymphoma
Investigated Drugs:
- Lenalidomide
- Tafasitamab
Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

Not recruiting

3 1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
+3
Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies